Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Anticancer Research
|
August 15, 2002
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients
Eleni Galani, Joseph Sgouros, Chariklia Petropoulou, et al.
Anticancer Research
|
August 19, 2007
Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group
Dimosthenis V Skarlos, Maria Bai, Anna Goussia, et al.
Oncology
|
July 23, 2009
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group
Dimosthenis V Skarlos, Eleni Timotheadou, Eleni Galani, et al.
Journal of Colloid and Interface Science
|
December 19, 2022
Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study
Sotiria Demisli, Eleni Galani, Maria Goulielmaki, et al.
Molecular and Clinical Oncology
|
February 20, 2016
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
Giannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, et al.
Plos One
|
March 19, 2014
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes
Giannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, et al.
HGG Advances
|
December 26, 2025
Understanding Exceptional Response: The Role of MINDY1 SNP in CDK4/6 Inhibitor Therapy for ER-Positive, HER2-Negative Advanced Breast Cancer
Eleni Balla, Yi Li, Zikun Zhou, et al.
Clinical Colorectal Cancer
|
September 21, 2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab
Alexios Strimpakos, George Pentheroudakis, Vassiliki Kotoula, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2015
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients
Anna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, et al.
Plos One
|
May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial
George Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Anticancer Research
|
August 15, 2002
Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients
Eleni Galani, Joseph Sgouros, Chariklia Petropoulou, et al.
Anticancer Research
|
August 19, 2007
Expression of a molecular marker panel as a prognostic tool in gastric cancer patients treated postoperatively with docetaxel and irinotecan. A study of the Hellenic Cooperative Oncology Group
Dimosthenis V Skarlos, Maria Bai, Anna Goussia, et al.
Oncology
|
July 23, 2009
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group
Dimosthenis V Skarlos, Eleni Timotheadou, Eleni Galani, et al.
Journal of Colloid and Interface Science
|
December 19, 2022
Encapsulation of cannabidiol in oil-in-water nanoemulsions and nanoemulsion-filled hydrogels: A structure and biological assessment study
Sotiria Demisli, Eleni Galani, Maria Goulielmaki, et al.
Molecular and Clinical Oncology
|
February 20, 2016
Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia
Giannis Mountzios, Gerasimos Aravantinos, Zoi Alexopoulou, et al.
Plos One
|
March 19, 2014
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes
Giannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, et al.
HGG Advances
|
December 26, 2025
Understanding Exceptional Response: The Role of MINDY1 SNP in CDK4/6 Inhibitor Therapy for ER-Positive, HER2-Negative Advanced Breast Cancer
Eleni Balla, Yi Li, Zikun Zhou, et al.
Clinical Colorectal Cancer
|
September 21, 2013
The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab
Alexios Strimpakos, George Pentheroudakis, Vassiliki Kotoula, et al.
Cancer Chemotherapy and Pharmacology
|
May 8, 2015
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients
Anna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, et al.
Plos One
|
May 14, 2015
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial
George Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, et al.
Page
of 3